| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lysophospholipids | 18 | 2023 | 67 | 2.960 |
Why?
|
| Sphingosine | 16 | 2023 | 73 | 2.720 |
Why?
|
| Endothelial Cells | 20 | 2025 | 500 | 2.050 |
Why?
|
| Lung | 25 | 2025 | 1406 | 1.710 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 11 | 2020 | 64 | 1.450 |
Why?
|
| Amifostine | 3 | 2024 | 50 | 1.430 |
Why?
|
| Endothelium, Vascular | 8 | 2018 | 440 | 1.410 |
Why?
|
| Reactive Oxygen Species | 12 | 2024 | 525 | 1.380 |
Why?
|
| Signal Transduction | 23 | 2024 | 3623 | 1.290 |
Why?
|
| Pseudomonas aeruginosa | 5 | 2021 | 206 | 1.160 |
Why?
|
| Acute Lung Injury | 6 | 2025 | 73 | 1.140 |
Why?
|
| Pseudopodia | 3 | 2018 | 39 | 1.140 |
Why?
|
| Paxillin | 2 | 2021 | 59 | 1.110 |
Why?
|
| Pseudomonas Infections | 3 | 2019 | 94 | 1.060 |
Why?
|
| Pneumonia | 5 | 2024 | 195 | 1.060 |
Why?
|
| Ventilator-Induced Lung Injury | 9 | 2023 | 33 | 1.030 |
Why?
|
| Capillary Permeability | 10 | 2015 | 133 | 1.030 |
Why?
|
| Mitochondrial Dynamics | 3 | 2024 | 61 | 1.020 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 5 | 2024 | 238 | 0.960 |
Why?
|
| Lipopolysaccharides | 8 | 2025 | 313 | 0.880 |
Why?
|
| Phospholipase D | 3 | 2020 | 13 | 0.810 |
Why?
|
| Inflammation | 9 | 2025 | 1121 | 0.800 |
Why?
|
| Blood-Air Barrier | 3 | 2020 | 6 | 0.800 |
Why?
|
| Cadherins | 4 | 2023 | 184 | 0.730 |
Why?
|
| Aldehyde-Lyases | 6 | 2021 | 14 | 0.700 |
Why?
|
| Sphingolipids | 2 | 2018 | 21 | 0.700 |
Why?
|
| Antigens, CD | 4 | 2020 | 484 | 0.680 |
Why?
|
| Receptors, Lysosphingolipid | 8 | 2023 | 38 | 0.660 |
Why?
|
| Mice | 37 | 2025 | 12698 | 0.650 |
Why?
|
| Lung Injury | 2 | 2019 | 61 | 0.650 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2020 | 6 | 0.630 |
Why?
|
| Cell Nucleus | 2 | 2021 | 615 | 0.600 |
Why?
|
| Animals | 48 | 2025 | 28899 | 0.580 |
Why?
|
| Epigenesis, Genetic | 3 | 2019 | 585 | 0.580 |
Why?
|
| Hepatocyte Growth Factor | 2 | 2016 | 86 | 0.580 |
Why?
|
| Phospholipids | 5 | 2012 | 109 | 0.570 |
Why?
|
| Mice, Inbred C57BL | 19 | 2024 | 3604 | 0.560 |
Why?
|
| Cells, Cultured | 17 | 2017 | 2854 | 0.550 |
Why?
|
| Cell-Derived Microparticles | 1 | 2017 | 13 | 0.530 |
Why?
|
| Anion Transport Proteins | 2 | 2016 | 10 | 0.530 |
Why?
|
| Phosphorylation | 6 | 2024 | 1145 | 0.530 |
Why?
|
| Endothelium | 4 | 2012 | 63 | 0.520 |
Why?
|
| NADPH Oxidases | 3 | 2016 | 87 | 0.510 |
Why?
|
| Cartilage, Articular | 1 | 2017 | 86 | 0.510 |
Why?
|
| Bleomycin | 5 | 2024 | 102 | 0.500 |
Why?
|
| Bronchopulmonary Dysplasia | 3 | 2021 | 48 | 0.480 |
Why?
|
| Whooping Cough | 2 | 2026 | 5 | 0.470 |
Why?
|
| Mitochondria | 5 | 2024 | 647 | 0.450 |
Why?
|
| Hyperoxia | 3 | 2021 | 37 | 0.450 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2015 | 30 | 0.440 |
Why?
|
| NADP | 1 | 2013 | 48 | 0.390 |
Why?
|
| Pneumonia, Bacterial | 1 | 2013 | 34 | 0.380 |
Why?
|
| Cell Movement | 1 | 2016 | 815 | 0.380 |
Why?
|
| Guanine Nucleotide Exchange Factors | 6 | 2010 | 76 | 0.370 |
Why?
|
| Humans | 52 | 2026 | 97883 | 0.360 |
Why?
|
| Aldehydes | 3 | 2021 | 21 | 0.360 |
Why?
|
| Free Radical Scavengers | 1 | 2011 | 59 | 0.350 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 446 | 0.330 |
Why?
|
| Bronchoalveolar Lavage Fluid | 6 | 2024 | 136 | 0.320 |
Why?
|
| Cell Cycle Proteins | 3 | 2020 | 419 | 0.310 |
Why?
|
| Cytoskeleton | 5 | 2024 | 200 | 0.300 |
Why?
|
| Bordetella pertussis | 2 | 2026 | 17 | 0.290 |
Why?
|
| Adherens Junctions | 4 | 2020 | 35 | 0.280 |
Why?
|
| Radiation-Protective Agents | 1 | 2008 | 98 | 0.270 |
Why?
|
| Phosphatidylcholines | 6 | 2011 | 49 | 0.260 |
Why?
|
| Cell Line | 7 | 2021 | 2482 | 0.240 |
Why?
|
| Macrolides | 1 | 2026 | 32 | 0.240 |
Why?
|
| Cytokines | 4 | 2019 | 889 | 0.240 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2024 | 94 | 0.230 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2026 | 89 | 0.220 |
Why?
|
| Endotoxins | 1 | 2025 | 36 | 0.220 |
Why?
|
| Placental Hormones | 1 | 2005 | 3 | 0.220 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2024 | 4 | 0.220 |
Why?
|
| Lactams, Macrocyclic | 1 | 2024 | 15 | 0.210 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2024 | 17 | 0.210 |
Why?
|
| Benzoquinones | 1 | 2024 | 27 | 0.210 |
Why?
|
| Fibroblasts | 3 | 2024 | 766 | 0.210 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2024 | 31 | 0.210 |
Why?
|
| Thrombin | 4 | 2020 | 60 | 0.210 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2024 | 45 | 0.210 |
Why?
|
| Inflammasomes | 1 | 2024 | 38 | 0.210 |
Why?
|
| rho-Associated Kinases | 2 | 2024 | 162 | 0.210 |
Why?
|
| Histone Deacetylases | 3 | 2021 | 85 | 0.210 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2024 | 112 | 0.210 |
Why?
|
| Phenazines | 1 | 2024 | 7 | 0.210 |
Why?
|
| Gentian Violet | 1 | 2024 | 9 | 0.210 |
Why?
|
| rac GTP-Binding Proteins | 3 | 2009 | 25 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2016 | 199 | 0.200 |
Why?
|
| Extracellular Vesicles | 1 | 2024 | 57 | 0.200 |
Why?
|
| Proteolysis | 1 | 2024 | 129 | 0.200 |
Why?
|
| Methanol | 2 | 2020 | 11 | 0.200 |
Why?
|
| Benzenesulfonates | 1 | 2024 | 49 | 0.200 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2024 | 90 | 0.200 |
Why?
|
| Sirtuin 1 | 1 | 2024 | 38 | 0.200 |
Why?
|
| Alveolar Epithelial Cells | 2 | 2020 | 18 | 0.200 |
Why?
|
| Mycoses | 1 | 2024 | 46 | 0.200 |
Why?
|
| Methyltransferases | 1 | 2025 | 218 | 0.200 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2024 | 95 | 0.200 |
Why?
|
| NAD | 1 | 2024 | 102 | 0.200 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2024 | 72 | 0.200 |
Why?
|
| Pyrrolidines | 2 | 2020 | 61 | 0.190 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2005 | 280 | 0.190 |
Why?
|
| Animals, Newborn | 2 | 2021 | 525 | 0.190 |
Why?
|
| Gene Knockdown Techniques | 5 | 2015 | 256 | 0.190 |
Why?
|
| Antioxidants | 3 | 2011 | 236 | 0.190 |
Why?
|
| Epithelial Cells | 3 | 2021 | 709 | 0.190 |
Why?
|
| Genetic Therapy | 1 | 2005 | 373 | 0.180 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2005 | 330 | 0.180 |
Why?
|
| Vascular Diseases | 1 | 2023 | 119 | 0.180 |
Why?
|
| Mice, Knockout | 7 | 2020 | 2206 | 0.180 |
Why?
|
| Minichromosome Maintenance Proteins | 1 | 2021 | 4 | 0.180 |
Why?
|
| DNA Primase | 1 | 2021 | 2 | 0.180 |
Why?
|
| Multifunctional Enzymes | 1 | 2021 | 10 | 0.180 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2021 | 22 | 0.180 |
Why?
|
| Gene Deletion | 2 | 2020 | 353 | 0.180 |
Why?
|
| Adenosine | 1 | 2025 | 291 | 0.170 |
Why?
|
| Recombinational DNA Repair | 1 | 2021 | 11 | 0.170 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2020 | 312 | 0.170 |
Why?
|
| Pulmonary Artery | 5 | 2023 | 342 | 0.170 |
Why?
|
| Receptor, TIE-2 | 1 | 2021 | 20 | 0.170 |
Why?
|
| BCG Vaccine | 1 | 2021 | 43 | 0.170 |
Why?
|
| Histones | 2 | 2021 | 363 | 0.170 |
Why?
|
| Tyrosine | 1 | 2021 | 135 | 0.170 |
Why?
|
| Microfilament Proteins | 2 | 2013 | 211 | 0.170 |
Why?
|
| DNA, Single-Stranded | 1 | 2021 | 95 | 0.170 |
Why?
|
| Male | 22 | 2025 | 46992 | 0.170 |
Why?
|
| Gene Expression Regulation | 4 | 2019 | 2019 | 0.170 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2021 | 79 | 0.160 |
Why?
|
| Carbapenem-Resistant Enterobacteriaceae | 1 | 2020 | 11 | 0.160 |
Why?
|
| DNA, Neoplasm | 1 | 2021 | 267 | 0.160 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2020 | 3 | 0.160 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2020 | 42 | 0.160 |
Why?
|
| Airway Remodeling | 1 | 2020 | 13 | 0.160 |
Why?
|
| Klebsiella pneumoniae | 1 | 2020 | 37 | 0.160 |
Why?
|
| Apoptosis | 5 | 2021 | 1752 | 0.160 |
Why?
|
| BRCA2 Protein | 1 | 2021 | 177 | 0.160 |
Why?
|
| Plasmalogens | 1 | 2020 | 2 | 0.160 |
Why?
|
| Melanoma | 1 | 2005 | 524 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 1 | 2026 | 872 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2014 | 370 | 0.150 |
Why?
|
| Iloprost | 2 | 2010 | 14 | 0.150 |
Why?
|
| Coronavirus | 1 | 2020 | 21 | 0.150 |
Why?
|
| RNA, Small Interfering | 8 | 2021 | 564 | 0.150 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 113 | 0.150 |
Why?
|
| Bibliometrics | 1 | 2020 | 49 | 0.150 |
Why?
|
| Asthma | 2 | 2021 | 1078 | 0.150 |
Why?
|
| Evolution, Molecular | 1 | 2026 | 902 | 0.150 |
Why?
|
| Regeneration | 1 | 2020 | 162 | 0.150 |
Why?
|
| Hypertension, Pulmonary | 1 | 2023 | 382 | 0.150 |
Why?
|
| Cyclic AMP | 3 | 2024 | 277 | 0.140 |
Why?
|
| Disease Models, Animal | 8 | 2021 | 2571 | 0.140 |
Why?
|
| Simvastatin | 1 | 2018 | 106 | 0.140 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2009 | 119 | 0.130 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2005 | 977 | 0.130 |
Why?
|
| Hyaluronan Receptors | 1 | 2017 | 41 | 0.130 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 332 | 0.130 |
Why?
|
| Chondrocytes | 1 | 2017 | 62 | 0.130 |
Why?
|
| Interleukin-1beta | 1 | 2017 | 92 | 0.130 |
Why?
|
| Oxidation-Reduction | 5 | 2010 | 418 | 0.130 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 337 | 0.120 |
Why?
|
| Cortactin | 1 | 2016 | 11 | 0.120 |
Why?
|
| Cell Cycle | 1 | 2018 | 518 | 0.120 |
Why?
|
| Membrane Proteins | 4 | 2023 | 1285 | 0.120 |
Why?
|
| Oxidative Stress | 3 | 2023 | 489 | 0.120 |
Why?
|
| Cell Proliferation | 2 | 2023 | 1790 | 0.120 |
Why?
|
| Catenins | 2 | 2012 | 13 | 0.110 |
Why?
|
| Respiration, Artificial | 2 | 2009 | 430 | 0.110 |
Why?
|
| Tyrphostins | 1 | 2015 | 7 | 0.110 |
Why?
|
| Transcription Factors | 2 | 2021 | 1717 | 0.110 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2015 | 30 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2020 | 470 | 0.110 |
Why?
|
| Lung Diseases | 1 | 2016 | 284 | 0.100 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2013 | 14 | 0.100 |
Why?
|
| Phosphoproteins | 2 | 2012 | 264 | 0.100 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 321 | 0.100 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2013 | 25 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1565 | 0.100 |
Why?
|
| rap1 GTP-Binding Proteins | 2 | 2012 | 10 | 0.100 |
Why?
|
| Blotting, Western | 4 | 2013 | 779 | 0.100 |
Why?
|
| Tight Junctions | 2 | 2012 | 158 | 0.100 |
Why?
|
| NADPH Oxidase 2 | 1 | 2013 | 23 | 0.100 |
Why?
|
| p21-Activated Kinases | 2 | 2010 | 17 | 0.100 |
Why?
|
| NADPH Oxidase 4 | 1 | 2013 | 15 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 285 | 0.090 |
Why?
|
| Chemotaxis | 1 | 2013 | 77 | 0.090 |
Why?
|
| China | 2 | 2026 | 277 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 215 | 0.090 |
Why?
|
| Telomere-Binding Proteins | 1 | 2011 | 14 | 0.090 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 2 | 2010 | 17 | 0.080 |
Why?
|
| Interleukin-6 | 2 | 2010 | 282 | 0.080 |
Why?
|
| Immunoglobulins | 1 | 2011 | 124 | 0.080 |
Why?
|
| HEK293 Cells | 2 | 2024 | 718 | 0.080 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2010 | 38 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 184 | 0.080 |
Why?
|
| Sulfones | 2 | 2020 | 48 | 0.080 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2010 | 58 | 0.080 |
Why?
|
| Pandemics | 2 | 2026 | 913 | 0.080 |
Why?
|
| Histone Deacetylase 2 | 2 | 2021 | 7 | 0.070 |
Why?
|
| Histone Deacetylase 1 | 2 | 2021 | 16 | 0.070 |
Why?
|
| Female | 8 | 2025 | 51464 | 0.070 |
Why?
|
| Caveolin 1 | 1 | 2009 | 24 | 0.070 |
Why?
|
| Membrane Microdomains | 1 | 2009 | 52 | 0.070 |
Why?
|
| Receptors, LDL | 1 | 2009 | 54 | 0.070 |
Why?
|
| Acetylation | 2 | 2021 | 150 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2009 | 310 | 0.070 |
Why?
|
| DNA Damage | 2 | 2021 | 399 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2010 | 448 | 0.060 |
Why?
|
| DNA, Complementary | 2 | 2005 | 380 | 0.060 |
Why?
|
| Epoprostenol | 1 | 2007 | 46 | 0.060 |
Why?
|
| Dinoprostone | 1 | 2007 | 80 | 0.060 |
Why?
|
| Fibronectins | 2 | 2020 | 104 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2025 | 4000 | 0.060 |
Why?
|
| Pertussis Vaccine | 1 | 2025 | 3 | 0.060 |
Why?
|
| rac1 GTP-Binding Protein | 3 | 2013 | 47 | 0.060 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2005 | 24 | 0.050 |
Why?
|
| Genome, Bacterial | 1 | 2026 | 144 | 0.050 |
Why?
|
| Retroviridae | 1 | 2005 | 74 | 0.050 |
Why?
|
| trans-Golgi Network | 1 | 2024 | 16 | 0.050 |
Why?
|
| Transgenes | 1 | 2005 | 173 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2005 | 155 | 0.050 |
Why?
|
| Cyclic GMP | 1 | 2024 | 63 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 582 | 0.050 |
Why?
|
| Methylation | 1 | 2025 | 294 | 0.050 |
Why?
|
| DNA Primers | 1 | 2005 | 530 | 0.050 |
Why?
|
| T-Lymphoma Invasion and Metastasis-inducing Protein 1 | 3 | 2009 | 7 | 0.050 |
Why?
|
| Hydrazones | 1 | 2023 | 7 | 0.050 |
Why?
|
| Global Health | 1 | 2025 | 215 | 0.050 |
Why?
|
| ADAM10 Protein | 1 | 2023 | 8 | 0.050 |
Why?
|
| Nanostructures | 1 | 2024 | 93 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2005 | 209 | 0.050 |
Why?
|
| Electric Impedance | 3 | 2009 | 118 | 0.050 |
Why?
|
| Analysis of Variance | 2 | 2019 | 889 | 0.050 |
Why?
|
| Cell Communication | 1 | 2024 | 223 | 0.050 |
Why?
|
| Transplantation, Heterologous | 1 | 2005 | 375 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2005 | 426 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2024 | 1646 | 0.050 |
Why?
|
| Vascular Remodeling | 1 | 2023 | 24 | 0.050 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2023 | 99 | 0.050 |
Why?
|
| Ribonucleases | 1 | 2003 | 89 | 0.050 |
Why?
|
| Protein Transport | 2 | 2016 | 447 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2024 | 161 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2024 | 200 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 889 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 1605 | 0.050 |
Why?
|
| Cell Survival | 2 | 2021 | 1014 | 0.050 |
Why?
|
| Stem Cells | 1 | 2024 | 396 | 0.040 |
Why?
|
| Child | 2 | 2025 | 7680 | 0.040 |
Why?
|
| Zonula Occludens-1 Protein | 2 | 2012 | 70 | 0.040 |
Why?
|
| Osteoblasts | 1 | 2021 | 97 | 0.040 |
Why?
|
| Genotype | 1 | 2026 | 1888 | 0.040 |
Why?
|
| Acyltransferases | 1 | 2021 | 57 | 0.040 |
Why?
|
| Genomic Instability | 1 | 2021 | 90 | 0.040 |
Why?
|
| DNA Helicases | 1 | 2021 | 91 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 2005 | 396 | 0.040 |
Why?
|
| Incidence | 1 | 2025 | 1776 | 0.040 |
Why?
|
| DNA Replication | 1 | 2021 | 169 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 2 | 2013 | 356 | 0.040 |
Why?
|
| Molecular Epidemiology | 1 | 2020 | 57 | 0.040 |
Why?
|
| Klebsiella Infections | 1 | 2020 | 35 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2021 | 146 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2021 | 519 | 0.040 |
Why?
|
| beta-Lactamases | 1 | 2020 | 58 | 0.040 |
Why?
|
| Plasmids | 1 | 2020 | 275 | 0.040 |
Why?
|
| RNA Interference | 2 | 2013 | 388 | 0.040 |
Why?
|
| Cell Count | 1 | 2020 | 195 | 0.040 |
Why?
|
| Internationality | 1 | 2020 | 79 | 0.040 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2020 | 80 | 0.040 |
Why?
|
| Phylogeny | 1 | 2026 | 1339 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2021 | 724 | 0.040 |
Why?
|
| Random Allocation | 2 | 2010 | 311 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2024 | 1944 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2020 | 160 | 0.040 |
Why?
|
| Vaccination | 1 | 2021 | 323 | 0.040 |
Why?
|
| Virulence | 1 | 2019 | 280 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2025 | 2063 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 2892 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2020 | 529 | 0.040 |
Why?
|
| Infant | 1 | 2025 | 3329 | 0.040 |
Why?
|
| Oligopeptides | 2 | 2010 | 205 | 0.040 |
Why?
|
| Pyridines | 1 | 2020 | 316 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2019 | 211 | 0.030 |
Why?
|
| Pregnancy | 1 | 2025 | 3246 | 0.030 |
Why?
|
| beta Catenin | 2 | 2011 | 267 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 1384 | 0.030 |
Why?
|
| Actins | 2 | 2013 | 480 | 0.030 |
Why?
|
| Smoking | 1 | 2021 | 674 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 286 | 0.030 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2016 | 42 | 0.030 |
Why?
|
| Microvessels | 1 | 2016 | 70 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 1394 | 0.030 |
Why?
|
| Drug Design | 1 | 2016 | 135 | 0.030 |
Why?
|
| Gene Expression | 1 | 2020 | 1320 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 1815 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 569 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 1254 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 319 | 0.030 |
Why?
|
| Ligands | 1 | 2016 | 487 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2016 | 679 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2020 | 900 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 55 | 0.030 |
Why?
|
| Phenotype | 1 | 2020 | 2638 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 212 | 0.020 |
Why?
|
| Allergens | 1 | 2013 | 196 | 0.020 |
Why?
|
| Mutation | 1 | 2024 | 4396 | 0.020 |
Why?
|
| Adolescent | 1 | 2025 | 10078 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2013 | 267 | 0.020 |
Why?
|
| Collagen | 1 | 2013 | 313 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 435 | 0.020 |
Why?
|
| Occludin | 1 | 2011 | 66 | 0.020 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2010 | 27 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2012 | 419 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2010 | 102 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 123 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 273 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2010 | 107 | 0.020 |
Why?
|
| Time Factors | 2 | 2009 | 5555 | 0.020 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 2009 | 13 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2011 | 291 | 0.020 |
Why?
|
| Rats | 2 | 2008 | 4070 | 0.020 |
Why?
|
| Microtubules | 1 | 2010 | 141 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2009 | 178 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2010 | 251 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2008 | 37 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2010 | 483 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2010 | 423 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2007 | 11 | 0.020 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2007 | 18 | 0.020 |
Why?
|
| Phosphatidic Acids | 1 | 2006 | 4 | 0.020 |
Why?
|
| Permeability | 1 | 2007 | 145 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 707 | 0.020 |
Why?
|
| Phosphatidylserines | 1 | 2006 | 21 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2006 | 425 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2006 | 225 | 0.010 |
Why?
|
| CD146 Antigen | 1 | 2005 | 4 | 0.010 |
Why?
|
| Immunomagnetic Separation | 1 | 2005 | 8 | 0.010 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2005 | 16 | 0.010 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2005 | 47 | 0.010 |
Why?
|
| von Willebrand Factor | 1 | 2005 | 43 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2005 | 435 | 0.010 |
Why?
|
| Carbon Tetrachloride | 1 | 2003 | 6 | 0.010 |
Why?
|
| Malondialdehyde | 1 | 2003 | 27 | 0.010 |
Why?
|
| Glutathione Peroxidase | 1 | 2003 | 26 | 0.010 |
Why?
|
| Catalase | 1 | 2003 | 46 | 0.010 |
Why?
|
| Lipid Peroxidation | 1 | 2003 | 46 | 0.010 |
Why?
|
| Alanine Transaminase | 1 | 2003 | 74 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 2003 | 74 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2003 | 116 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 2003 | 173 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 2003 | 155 | 0.010 |
Why?
|
| Cholesterol | 1 | 2005 | 373 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 883 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 642 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1946 | 0.010 |
Why?
|
| Liver | 1 | 2003 | 1229 | 0.010 |
Why?
|
| Oxygen | 1 | 2003 | 772 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2005 | 802 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2005 | 3202 | 0.010 |
Why?
|
| Obesity | 1 | 2005 | 1061 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 21702 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 29353 | 0.010 |
Why?
|